Cvs Health (CVS) Cash & Equivalents (2009 - 2026)

Cvs Health (CVS) has 18 years of Cash & Equivalents data on file, last reported at $9.5 billion in Q1 2026.

• Quarterly Cash & Equivalents fell 5.3% year-over-year to $9.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.5 billion (down 5.3% YoY) and the FY2025 annual result came in at $8.5 billion, down 1.55% from the prior year.
• Cash & Equivalents climbed to $9.5 billion in Q1 2026, from $8.5 billion in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $17.2 billion in Q3 2022 to a low of $6.9 billion in Q3 2024.
• A 5-year average of $11.0 billion and a median of $10.1 billion in 2025 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents jumped 75.02% — and 2024, when it plunged 47.29%.
• Tracing CVS's Cash & Equivalents over 5 years: stood at $12.9 billion in 2022, then sank by 36.69% to $8.2 billion in 2023, then climbed by 4.76% to $8.6 billion in 2024, then decreased by 1.55% to $8.5 billion in 2025, then advanced by 12.88% to $9.5 billion in 2026.
• The last three Cash & Equivalents figures came in at $9.5 billion (Q1 2026), $8.5 billion (Q4 2025), and $9.1 billion (Q3 2025), per Business Quant data.